All news articles for January 2020

Takeda forms broad drug discovery pact with Charles River

21-Jan-2020 By Nick Taylor

Takeda tasks Charles River with sorting through “plethora” of early stage assets.

Drug discovery service provider Schrödinger files for $100M IPO

20-Jan-2020 By Nick Taylor

Schrödinger files for $100m IPO after establishing itself as a drug discovery partner to big pharma.

Merck looks to CMOs to help ease vaccine supply bottleneck

20-Jan-2020 By Nick Taylor

Merck enlists CMOs to help increase Gardasil manufacturing capacity in response to rising demand.

Funding for AI startups dries up

17-Jan-2020 By Ben Hargreaves

The number of startup companies emerging and the funding that they received took a sharp downturn in 2019.

Bayer expands women’s health pact with Evotec

16-Jan-2020 By Nick Taylor

Bayer signs five-year, multi-target women’s health collaboration with Evotec, expanding on earlier deal.

PPD, seeking $100m IPO, reveals rapid revenue growth

16-Jan-2020 By Nick Taylor

PPD reveals revenues almost doubled between 2014 and 2018 in filing to raise $100m from public investors.

Surging local demand drives 24% growth of Korean contract service sector

15-Jan-2020 By Nick Taylor

South Korean contract service market grows 24% as local biopharma companies step up spending.

Alcami sells Dutch API facility to MercachemSyncom

14-Jan-2020 By Ben Hargreaves

Alcami downsizes in Europe through the sale of its API facility to MercachemSyncom, as it expands its presence in North America.

Yposkesi doubles manufacturing footprint to meet AAVs growing demand

14-Jan-2020 By Vassia Barba

Yposkesi CDMO announces expansion to cover growing demand, strikes a deal on viral vectors production for a gene therapy development project.

FDA places Innate cancer trial on partial clinical hold over CMO issue

14-Jan-2020 By Nick Taylor

The US FDA puts Innate Pharma trial on partial clinical hold after learning of CMO problems.

CRO Veristat buys TCTC Group to expand in Europe

13-Jan-2020 By Nick Taylor

Veristat buys The Clinical Trial Company to establish presence in the European contract research sector.

Bristol-Myers offloads manufacturing plant to Catalent

13-Jan-2020 By Nick Taylor

Catalent buys Italian manufacturing and packaging plant from Bristol-Myers Squibb, adding oral solid, biologics and sterile product capacity.

Bayer, Schrödinger partner on compound developing software project

13-Jan-2020 By Vassia Barba

Bayer to work with Schrödinger on a molecule design software, which will be integrated into the latter’s LiveDesign, a digital drug design platform.

Signant and Propeller partner to improve inhaler adherence with sensor

09-Jan-2020 By Ben Hargreaves

The two companies will combine their digital health services to offer clinical trial participants an inhaler equipped with a sensor to analyze patient adherence.

WuXi Biologics and Almirall partner to develop dermatological treatments

09-Jan-2020 By Vassia Barba

Almirall enters drug discovery agreement with WuXi Biologics, gaining access to the WuXiBody platform to develop antibodies for the treatment of dermatological diseases.